Keep taking the tablets

The IPKat notes that the ECJ will be delivering its judgment in the Boehringer Ingelheim parallel importation case this Thurusday. In this round of the ongoing mega-case, the England and Wales Court of Appeal has referred questions on the trade mark implications of:

  • repackaging

  • overstickering

  • the relevant notice that must be given by a repackaging to the trade mark proprietor

The IPKat will bring you news of the result ASAP on Thursday.

Keep taking the tablets Keep taking the tablets Reviewed by Anonymous on Monday, April 23, 2007 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.